Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?
As the biotechnology landscape shifts toward personalized medicine and advanced computing, investors are weighing established leaders against emerging tech-driven disruptors. Moderna (MRNA +9.99%) and Recursion Pharmaceuticals (RXRX +3.54%) offer…
Nifty holds above 24,350 at noon; IT, Pharma and Financials lead broad rally
Markets maintained firm gains through the first half of trade on Friday, with the Sensex up 539.09 points or 0.70 per cent at 78,041.21 and the Nifty 50 higher by 182.10 points or 0.75 per cent at 24,357.80, as of 12.55 PM. The session so far has…
Moscow's SEZ Pharma Players Pour 1.7× More Investments Into City's Economy
The top investor in January-March 2026 was a pharmaceutical company currently conducting clinical trials of a drug targeting 30 types of cancer. The resident company has also developed four biosimilars for the treatment of melanoma, non-small cell…
USS Investment Management Ltd Boosts Position in Royalty Pharma PLC $RPRX
USS Investment Management Ltd increased its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 21.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.
Stock markets take winning run to 3rd day
Benchmark equity indices Sensex and Nifty ended higher on Friday, extending their winning momentum to the third day running, amid a rally in IT stocks and a softer-than-expected US jobs data tempering expectations of near-term monetary tightening…
GTA 6 And Take-Two Interactive: The 'Rebel Strategy' Driving A Gaming Titan
Take-Two is a blockbuster machine with games like GTA 6 but also has annual revenue through sports and mobile games. SOPA Images/LightRocket via Getty Images Grand Theft Auto 6 is expected to sell up to 40 million copies in a single day when it…
Anthropic wants to develop its own drugs
The AI drug boom has a long way to go before reaching patients. The AI drug boom has a long way to go before reaching patients. If you buy something from a Verge link, Vox Media may earn a commission. See our ethics statement. Robert Hart is a…
A $500 Million Funding Deal Could Make Mineralys Therapeutics (MLYS) Stock A Multibagger
Mineralys Therapeutics Inc. (NASDAQ: MLYS) is one of the 8 Hidden Multibagger Stocks to Buy Now. During the last few trading sessions, Mineralys Therapeutics Inc. (NASDAQ:MLYS) has seen positive momentum. On June 4, Goldman Sachs analyst Richard…
Orion publishes Half-Year Report for January-June 2026 and holds a webcast on 17 July 2026
Orion publishes Half-Year Report for January–June 2026 and holds a webcast on 17 July 2026 Orion will publish Half-Year Report for January–June 2026 on Friday, 17 July 2026 at approximately 12.00 noon EEST. The report and related…
India's luxury homebuyer is changing, and so is the market
The face of India's luxury homebuyer is changing. For decades, the country's most expensive homes were the preserve of legacy business families and industrialists. Today, a different kind of buyer is walking into luxury sales offices —…
Stock markets take winning run to third day; Sensex climbs 262 points
Benchmark equity indices Sensex and Nifty ended higher on Friday (July 3, 2026), extending their winning momentum to the third day running, amid a rally in IT stocks and a softer-than-expected U.S. jobs data tempering expectations of near-term…
Nanalysis Announces Grant of Options and Restricted Share Units
CALGARY, AB, July 3, 2026 /CNW/ - Nanalysis Scientific Corp. (the 'Company' or 'Nanalysis') (TSXV: NSCI, FRA: 1N1) announces the Company's Board of Directors has granted 100,000 stock options ('Options') to a director and officer of the Company…
Sensex, Nifty Extend Winning Streak on IT Stocks Rally, Global Rate Hopes
Indian benchmark equity indices, Sensex and Nifty, extended their winning streak for a third consecutive day, driven by a rally in IT stocks and global cues suggesting a more accommodative monetary policy after softer-than-expected US jobs data.
−320°F, Sadler's Wells review: The latest bonkers spectacle from Japan's Hideki Noda is hilarious, visually stunning and way too long
The latest bonkers spectacle from Japan's Hideki Noda is hilarious, visually stunning and way too long Theatre, Experimental Sadler's Wells, Clerkenwell Recommended The title of Hideki Noda's latest play is ‘minus three twenty Fahrenheit'…
Market today: Sensex sustains over 78,000 mark, Nifty above 24,300 as IT stocks extend rally HCL Tech jumps
Domestic equity benchmarks traded higher at midday on Friday, led by information technology stocks, after a softer-than-expected US jobs report eased concerns over near-term Federal Reserve rate hikes and boosted risk appetite for emerging markets.
Receive a Daily briefing on Pharma Industry News
Get Started